What is the interpretation of this complete blood count: RBC 5.96 ×10⁶/µL (elevated), hemoglobin 11.2 g/dL (low‑normal), hematocrit 39.7 % (normal), mean corpuscular volume 67 fL (low), mean corpuscular hemoglobin 18.8 pg (low), mean corpuscular hemoglobin concentration 28.2 g/dL (low), red cell distribution width 16.0 % (high)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Microcytic Anemia with Elevated RBC Count: Iron Deficiency or Thalassemia Trait

This CBC pattern—markedly low MCV (67 fL), low MCH (18.8 pg), low MCHC (28.2 g/dL), elevated RBC count (5.96), and elevated RDW (16.0%)—is most consistent with iron deficiency anemia, though beta thalassemia trait remains an important differential that must be excluded.

Key Diagnostic Features

The combination of findings points to a microcytic, hypochromic anemia:

  • Microcytosis: MCV 67 fL (significantly below normal 79-97 fL)
  • Hypochromia: MCH 18.8 pg and MCHC 28.2 g/dL (both markedly reduced)
  • Elevated RBC count: 5.96 despite borderline-low hemoglobin
  • Increased RDW: 16.0% indicates significant variation in red cell size (anisocytosis)

1 confirms that low MCV typically suggests iron deficiency, folate/B12 deficiency, or inherited hemoglobin synthesis disorders.

Distinguishing Iron Deficiency from Thalassemia Trait

The elevated RDW strongly favors iron deficiency over thalassemia trait, where RDW is typically normal or only mildly elevated. However, definitive differentiation requires:

Immediate Next Steps:

  1. Iron studies (prioritize these):

    • Serum ferritin: <25 ng/mL (males) or <11 ng/mL (females) indicates iron deficiency 1
    • Transferrin saturation: More reliable than ferritin as it's less affected by inflammation 1
  2. Hemoglobin electrophoresis/HPLC if iron studies are normal:

    • Beta thalassemia trait typically shows MCV ≤73.8 fL and MCH ≤21.9 pg with >90% sensitivity 2
    • Your patient's values (MCV 67, MCH 18.8) fall well below these thresholds, making thalassemia trait possible

Clinical Algorithm

If ferritin <25 ng/mL or transferrin saturation low:

  • Diagnose iron deficiency anemia
  • Investigate source of blood loss (GI bleeding most common in non-menstruating patients) 1
  • Initiate iron supplementation

If iron studies are normal:

  • Proceed to hemoglobin electrophoresis/HPLC
  • Beta thalassemia trait will show elevated HbA2 (>3.5%)
  • HbE trait shows characteristic HPLC pattern 2

Critical Pitfalls to Avoid

  • Do not assume iron deficiency without confirmation: The elevated RBC count (5.96) is unusual for pure iron deficiency and raises suspicion for thalassemia trait, where the bone marrow compensates by producing more (albeit smaller) red cells
  • Ferritin can be falsely elevated as an acute-phase reactant in inflammation 1; if clinical suspicion for iron deficiency remains high despite normal ferritin, check transferrin saturation
  • Do not overlook occult GI bleeding: In adults without obvious blood loss, iron deficiency warrants GI evaluation 1

Why This Pattern Matters

The hemoglobin of 11.2 g/dL is at the lower limit of normal, but the profoundly microcytic indices (MCV 67) indicate this patient has been compensating with increased RBC production. This represents significant pathology requiring investigation, not a benign finding.

References

Guideline

clinical practice guidelines for evaluation of anemia.

Kidney International Supplements, 2008

Related Questions

What does a complete blood count with RBC 3.70 ×10^12/L, hemoglobin 12.1 g/dL, hematocrit 36.3 %, mean corpuscular volume 98.1 fL, and mean corpuscular hemoglobin 32.7 pg indicate, and what are the appropriate next diagnostic and therapeutic steps?
Interpret the complete blood count results showing hemoglobin 7.8 g/dL, hematocrit 27.7 %, mean corpuscular volume 71 fL, mean corpuscular hemoglobin 20 pg, mean corpuscular hemoglobin concentration 28.2 g/dL, and red cell distribution width 18.7 %.
Interpret the complete blood count for a female patient with hemoglobin 11.9 g/dL, hematocrit 40 %, MCV 71 fL, MCH 21.2 pg, MCHC 29.8 g/dL, and RDW 20 %.
What are the normal lab value ranges in a Complete Blood Count (CBC) with differential?
How should I interpret a complete blood count showing low red blood cell count, low hemoglobin, low hematocrit, borderline macrocytosis, elevated red‑cell distribution width, mild thrombocytopenia, and modest eosinophilia, and what immediate work‑up and management steps are recommended?
In a 71‑year‑old woman with a two‑month history of daily bilateral ankle pain (right greater than left), swelling without erythema, no fever, no recent trauma, pain that worsens toward the end of the day and improves with leg elevation, and a normal right‑ankle radiograph, what is the most likely diagnosis and appropriate management?
What is the appropriate diagnostic and therapeutic approach for adrenal insufficiency in ICU patients?
What is the appropriate pseudoephedrine dosage and treatment duration for an adult patient with nasal congestion who has asthma and is using a fluticasone‑salmeterol (Advair) inhaler?
How does a subdural hygroma increase the risk of intracranial bleeding in a patient taking a direct oral anticoagulant (DOAC)?
As the primary care physician for a 79‑year‑old woman who fell onto the edge of a pool and now has right‑knee swelling, pain, stiffness, and a stiff gait, can you interpret the knee imaging (radiographs) to rule out a fracture?
What is basal cell carcinoma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.